FDA Cracks Down on Salmonella in Egg Hauling Rules
Published Date: 9/25/2025
Notice
Summary
The FDA wants to update how egg producers keep track of their eggs to stop Salmonella from making people sick. This affects farmers, packers, and transporters who handle shell eggs, asking them to share some info in new ways. The goal? Safer eggs without extra costs or delays, and the government is checking the plan now.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
New egg tracking information requests
If you are a farmer, packer, or transporter who handles shell eggs, the FDA is asking you to share certain information in new ways so officials can track eggs to prevent Salmonella Enteritidis. The FDA submitted this proposed information collection to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995.
Goal: Safer eggs for consumers
The FDA's plan aims to make shell eggs safer to reduce illness from Salmonella Enteritidis. The agency says the goal is safer eggs without extra costs or delays, and it has sent the plan to OMB for review.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10321 — Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.
The FDA is holding a public meeting on June 18, 2026, to talk about the safety and effectiveness of MFLUSIVA, a new flu vaccine made by Moderna. Anyone can watch online and share their thoughts before June 17. This is a big deal for people who get flu shots and could affect how this vaccine is used and approved.
2026-10295 — M11 Clinical Electronic Structured Harmonised Protocol (CeSHarP); International Council for Harmonisation; Guidance for Industry; Availability
The FDA just released a new, easy-to-use digital guide called M11 CeSHarP to help everyone involved in clinical trials share and review study plans faster and clearer. This affects drug companies, researchers, and regulators worldwide by setting a global standard for how trial info is written and shared electronically. The new rules kick in now, aiming to save time and reduce confusion, with no direct cost but big efficiency gains.
2026-10277 — Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
The FDA just released new draft guides to help drug makers design studies proving their generic drugs work like the originals. If you’re in the drug business, now’s your chance to share feedback by July 21, 2026, before these guides become final. These updates aim to speed up drug approvals, potentially saving time and money for companies and patients alike!
2026-10284 — Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Guidance for Industry; Availability
The FDA just released new guidance to help baby formula makers prove their products have good-quality protein using special rat studies. This update affects formula manufacturers and labs, making it easier and clearer to show their formulas meet nutrition standards. The guidance is effective now, helping companies avoid costly mistakes and speed up getting new formulas to market.
2026-10268 — Notice of Decision Not To Designate Hepatitis Delta Virus Diseases as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
The FDA decided not to add Hepatitis Delta Virus (HDV) to the list of tropical diseases because it doesn’t fully meet the rules about market size and who it affects. This means drug makers won’t get special priority review vouchers for HDV treatments right now. People working on HDV drugs should keep an eye out for future updates but won’t see changes or new incentives immediately.
2026-10190 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions
The FDA is updating how companies ask for extra patent time when their new drugs or devices take a while to get approved. This affects drug and medical device makers who want to protect their inventions longer. Comments on these changes are open until June 22, 2026, and the update aims to keep the process clear without adding extra costs or delays.
Previous / Next Documents
Previous: 2025-18616 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration of Food Facilities
The FDA wants to keep food safe by updating how food facilities register with them. This affects anyone who makes or handles food and might mean some new forms or info to share. They’re asking for feedback now and aiming to keep things smooth without extra costs or delays.
Next: 2025-18619 — Notice of Final Federal Agency Action on the Authorization for the Port of Corpus Christi Authority Harbor Island Desalination Project
The U.S. Army Corps of Engineers has given the green light to build a new desalination plant at the Port of Corpus Christi, which will help turn seawater into fresh water. This decision affects local waterways and starts a 2-year window for any legal challenges. The project promises to boost water supply without costing taxpayers extra right now, and construction can move forward soon!